...
首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells.
【24h】

Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells.

机译:带有双基因系统的慢病毒载体可在选定的多克隆人胚胎干细胞中高效且均质地表达转基因。

获取原文
获取原文并翻译 | 示例

摘要

Genetic modification of human embryonic stem cells (hESCs) is highly valuable for their exploitation in basic science and therapeutic applications. Here we developed lentiviral vectors (LVs) constitutively expressing a reporter and a selectable marker to enable high and homogeneous transgene expression within polyclonal hESCs. LVs carrying GFP and a downstream puromycin resistance gene, linked by the encephalomyocarditis virus (EMCV) or poliovirus internal ribosome entry sites (IRES), allowed homogeneous GFP expression after antibiotic selection. The GFP-expression levels were higher with the EMCV IRES. We also developed dual-promoter vectors harboring a reporter and an antibiotic resistance gene under the regulation of human EF1alpha and PGK1 promoters, respectively. Optimal efficiency was obtained when: (1) the reporter cassette was upstream rather than downstream of the selectable marker cassette, (2) the puromycin rather than the neomycin resistance gene was used, (3) a 5' deletion (314 bp) was created in the PGK promoter, and (4) two copies of a 120-bp element derived from the hamster Aprt CpG island were introduced upstream of the EF1alpha promoter. In summary, we developed bicistronic and novel dual-promoter LVs that enable high and homogeneous expression of transgenes by polyclonal hESCs after antibiotic selection. These vectors may provide important tools for basic and applied research on hESCs.
机译:人类胚胎干细胞(hESCs)的基因修饰对于其在基础科学和治疗应用中的开发非常有价值。在这里,我们开发了组成型表达报告基因和选择标记的慢病毒载体(LVs),以在多克隆hESC中实现高均质的转基因表达。 LV携带GFP和下游的嘌呤霉素抗性基因,通过脑心肌炎病毒(EMCV)或脊髓灰质炎病毒内部核糖体进入位点(IRES)相连,在选择抗生素后允许GFP均匀表达。使用EMCV IRES,GFP表达水平更高。我们还开发了双启动子载体,分别在人类EF1alpha和PGK1启动子的调控下具有报告基因和抗生素抗性基因。在以下情况下可获得最佳效率:(1)报告基因盒位于选择标记盒的上游而不是下游;(2)使用嘌呤霉素而不是新霉素抗性基因;(3)产生5'缺失(314 bp)在PGK启动子中,(4)从仓鼠Aprt CpG岛得到的两个120 bp元件的拷贝被引入到EF1alpha启动子的上游。总之,我们开发了双顺反子和新型双启动子LV,在选择抗生素后,它们可通过多克隆hESCs高而均一地表达转基因。这些载体可能为hESC的基础和应用研究提供重要工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号